From available case reports, compounding pharmacy data, and practitioner experience, the following have been observed: BPC-157 Reported Side Effects Nausea and gastrointestinal discomfort (especially with oral administration) Dizziness or light-headedness Flushing or warmth at injection sites Headache Fatigue or somnolence in some users TB-500 Reported Side Effects Injection site reactions (redness, mild pain, swelling) Transient fatigue or lethargy following administration Headache Possible flu-like symptoms in a minority of users Critical Risk Note: Because neither peptide has undergone full clinical trial evaluation in humans, the complete adverse event profile is unknown
If you have a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or if youre pregnant, breastfeeding, or planning to become pregnant, we offer our Rapid or Standard Program but not Compounded Semaglutide
When on these medications, it is critical to be mindful of the importance of diet and nutrition to your health
Many people successfully maintain their weight loss after stopping GLP-1 medications, especially when they: Stay active Eat enough protein Continue healthy routines Monitor weight regularly Address emotional eating Focus on long-term consistency However, maintenance usually requires ongoing effort
